The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-[4-(3-Heptyl-phenyl)-but-1-enyl]-2-(2-methyl-cyclopropyl)-4,5-dihydro-thiazole ID: ALA89124
PubChem CID: 44323009
Max Phase: Preclinical
Molecular Formula: C24H35NS
Molecular Weight: 369.62
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCCCc1cccc(CC/C=C\[C@@H]2CSC([C@@H]3C[C@@H]3C)=N2)c1
Standard InChI: InChI=1S/C24H35NS/c1-3-4-5-6-7-11-20-13-10-14-21(17-20)12-8-9-15-22-18-26-24(25-22)23-16-19(23)2/h9-10,13-15,17,19,22-23H,3-8,11-12,16,18H2,1-2H3/b15-9-/t19-,22+,23+/m0/s1
Standard InChI Key: JJFNYMYMBCMWBD-FQWYBILGSA-N
Molfile:
RDKit 2D
28 30 0 0 1 0 0 0 0 0999 V2000
9.5917 -4.8375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0417 -5.5167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4917 -6.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7667 -4.8375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.8667 -5.4667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8417 -4.0542 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.5125 -4.0542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7250 -3.8000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1875 -3.5667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9000 -3.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3625 -5.0875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5542 -5.0292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1875 -5.1250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9167 -5.7875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1292 -6.5542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4542 -4.4625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3042 -6.5250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5750 -5.8542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6292 -4.4250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0917 -5.7542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6500 -6.4500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1167 -7.7750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5625 -7.0792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8292 -6.4167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3875 -7.1125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7083 -7.7375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4417 -6.0875 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
11.4167 -6.0792 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 1 2 0
5 2 1 0
6 1 1 0
7 4 1 0
7 8 1 6
9 6 1 0
10 8 2 0
11 13 2 0
12 5 1 0
13 19 1 0
14 11 1 0
15 18 2 0
16 10 1 0
17 15 1 0
18 13 1 0
19 16 1 0
20 14 1 0
21 20 1 0
22 23 1 0
23 25 1 0
24 21 1 0
25 24 1 0
26 22 1 0
2 27 1 6
5 28 1 6
7 9 1 0
3 5 1 0
17 14 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 369.62Molecular Weight (Monoisotopic): 369.2490AlogP: 6.86#Rotatable Bonds: 11Polar Surface Area: 12.36Molecular Species: NEUTRALHBA: 2HBD: ┄#RO5 Violations: 1HBA (Lipinski): 1HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 4.48CX LogP: 7.93CX LogD: 7.93Aromatic Rings: 1Heavy Atoms: 26QED Weighted: 0.31Np Likeness Score: 1.29
References 1. Wipf P, Reeves JT, Balachandran R, Day BW.. (2002) Synthesis and biological evaluation of structurally highly modified analogues of the antimitotic natural product curacin A., 45 (9): [PMID:11960501 ] [10.1021/jm0105171 ] 2. Nishikawa A, Shirai R, Koiso Y, Hashimoto Y, Iwasaki S. (1997) Design and synthesis of curacin a analogs with varied side chain structures, 7 (20): [10.1016/S0960-894X(97)10055-5 ]